HIGHLIGHTS
- who: MMP- and collaborators from the Montpellier Cancer Institute between March , and December , was quantified in serum samples by have published the research: Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer, in the Journal: (JOURNAL)
- what: The authors assessed with an immunoassay the authors developed the prognostic value of MMP-7 in a series of patients with advanced Methods: samples were collected from 56 patients with advanced who were treated at the Montpellier Institute between March 2003 and December 2004. The authors measured MMP-7 serum levels particularly in patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.